Appletreeclinics Network Sp. z o.o.
- Address
- lock Available on a paid plan
Dermatology and Immune-Mediated Skin Diseases
At Appletreeclinics Ośrodek Badań Klinicznych in Lodz, research in skin and connective tissue diseases and immune system diseases is focused on conditions such as atopic dermatitis and moderate to severe plaque psoriasis. These studies are designed to assess new treatment options and better understand how to improve symptom control and long-term disease management.
- Evaluating new therapies for moderate to severe atopic dermatitis
- Studying treatment effects in moderate to severe plaque psoriasis
- Assessing the safety of longer-term care for chronic inflammatory skin disease
This area of research brings together efforts to improve both effectiveness and safety for people living with persistent inflammatory skin conditions.
Gastroenterology and Inflammatory Bowel Disease
Clinical trials at this site also cover digestive system diseases, with a strong focus on moderate to severe ulcerative colitis. The research is centered on evaluating long-term treatment safety and supporting better disease control for patients with chronic intestinal inflammation.
- Investigating treatment safety in ulcerative colitis
- Monitoring long-term outcomes in gastrointestinal inflammation
- Supporting improved management of chronic bowel disease
These studies help expand knowledge about therapies aimed at reducing disease burden and maintaining stable control over time.
Neurology and Migraine Prevention
Research in nervous system diseases includes trials for migraine, with an emphasis on finding better ways to prevent attacks and improve daily functioning for adults affected by recurrent headaches. The work is aimed at testing whether emerging preventive approaches can offer meaningful relief where previous treatments have not been enough.
- Exploring new options for migraine prevention
- Focusing on patients with ongoing headache burden
- Evaluating whether preventive treatment can improve quality of life
This line of research reflects the site’s interest in neurological conditions that can significantly affect everyday activity and well-being.
Behavioral Health and Nicotine Cessation
The site also participates in psychiatry and psychology research related to behavior and behavior mechanisms, including studies on stopping electronic cigarette and tobacco use. These trials aim to evaluate whether adding behavioral support to medication can improve quit rates for people motivated to stop vaping or smoking.
- Supporting cessation of electronic cigarette use
- Addressing dual use of vaping and tobacco products
- Testing approaches that combine medication and behavioral support
This research focuses on practical strategies to help people break nicotine dependence and maintain abstinence over time.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Appletreeclinics Network Sp. z o.o.
lock Showing 1 of 11 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3, Randomized, 24-week, Placebo-controlled, Double-blind Study to Assess the Efficacy, Safety and Tolerability of Rocatinlimab (AMG 451) Monotherapy in Adult Subjects With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon) | Amgen Inc. | Phase III | Not Recruiting | Apr 2023 | Jun 2025 |
IMP list
lock Showing 1 of 6 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Obefazimod | 3 | Unknown | 2021-12-01 | 2021-12-01 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.
